Zymar

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:Ophthalmology
gptkbp:available_on generic version
gptkbp:brand gptkb:Zymar
gptkbp:class gptkb:pharmaceuticals
fluoroquinolone antibiotic
gptkbp:clinical_trial Phase III
studied in randomized controlled trials
gptkbp:clinical_use ophthalmology
gptkbp:community_service safety and efficacy not established in children under 1 year
gptkbp:contraindication hypersensitivity to gatifloxacin
gptkbp:dosage_form gptkb:Software_Solutions
gptkbp:drug_interactions none known
gptkbp:duration 7 days
gptkbp:effective_date gptkb:2003
gptkbp:excretion urine
gptkbp:formulation gptkb:cream
sterile solution
https://www.w3.org/2000/01/rdf-schema#label Zymar
gptkbp:indication treatment of bacterial infections of the eye
gptkbp:ingredients gptkb:gatifloxacin
gptkbp:invention patent expired
gptkbp:lifespan 5 to 7 hours
gptkbp:manufacturer gptkb:Allergan
gptkbp:marketed_as gptkb:Canada
gptkb:European_Union
gptkb:United_States
gptkbp:mechanism_of_action inhibits bacterial DNA gyrase
gptkbp:metabolism minimal hepatic metabolism
gptkbp:packaging gptkb:bottle
gptkbp:patient_population available online
adults and children
gptkbp:pharmacokinetics well-studied
rapidly absorbed
gptkbp:price varies by pharmacy
gptkbp:provides_guidance_on gptkb:American_Academy_of_Ophthalmology
gptkbp:regulatory_compliance FDA approved
gptkbp:requires available online
prescription only
gptkbp:route_of_administration topical
ocular
gptkbp:safety_features generally well tolerated
gptkbp:safety_measures use in lactation only if needed
use in pregnancy only if needed
gptkbp:service_frequency every 2 hours for the first 2 days
gptkbp:shelf_life 24 months
gptkbp:side_effect headache
nausea
dry eyes
vomiting
eye irritation
taste disturbance
gptkbp:storage room temperature
gptkbp:used_for bacterial conjunctivitis
gptkbp:bfsParent gptkb:Bausch_+_Lomb_Eye_Products_Inc.
gptkb:Valeant_Pharmaceuticals
gptkbp:bfsLayer 6